CHNA

Loncar China BioPharma ETF

$26.20
$0.01
(0.04%)
As of 1:00:00 AM EDT | 2/14/20  |  Market Closed

CHNA Trading Data

Open

$26.23

Low Price

$26.14

High Price

$26.24

Previous Last Price

$26.2

Bid Size

$0 X 0

Ask Size

$0 X 0

CHNA Portfolio Data

AUM

$12,445,000

Shares

475

PE Ratio

18.16

Price / Book Ratio

3.06

Expense Ratio

0.79

Net Asset Value

$26.20

Volume

Volume

1,000

Avg. Volume (YDT)

5,074

Dollar Volume

$32,020

Weekly Avg. Volume

5,240

Monthly Avg. Volume

6,410

Quarterly Avg. Volume

4,805

CHNA Fund Description

The China BioPharma ETF offers exposure to a basket of companies powering China's biopharmaceutical industry. With a long-term goal of steering its economy towards innovation, China aims be a global leader in medicine. CHNA seeks to invest in this opportunity with the convenience of one security that trades in the United States. It invests in pharmaceutical companies, biotech companies,drug manufacturers, diagnostics companies, wholesalers, distributors, and service providers that have a strategic focus in growing China's drug industry.

CHNA Chart

CHNA Summary

Fund Family

Exchange Traded Concepts

Tracks This Index

Loncar China BioPharma ETF

Inception Date

2018-08-14

Asset Class

Equity

Asset Class Size

CHNA Classification

Region (General)

Asia-Pacific

Region (Specific)

China

Sector

Health Care

Equity Index

Leveraged Family

CHNA Holdings

Top 10 Holdings

WUXI APPTEC CO LTD (2359 HK)
6.07%
CANSINO BIOLOGICS (6185 HK)
6%
CSPC PHARMACEUTICA (1093 HK)
5.92%
WUXI BIOLOGICS (CA (2269 HK)
5.17%
ZAI LAB LTD (ZLAB)
4.62%
SINO BIOPHARMACEUT (1177 HK)
4.6%
LIVZON PHARMACEUTI (1513 HK)
4.58%
HANSOH PHARMACEUTI (3692 HK)
4.51%
CHINA MEDICAL SYS (867 HK)
3.97%
HUTCHISON CHINA MEDITECH LTD SPONSORED ADR (HCM)
3.59%

Total CHNA Holdings

Total Holdings: 31

WUXI APPTEC CO LTD (2359 HK)
6.07%
CANSINO BIOLOGICS (6185 HK)
6%
CSPC PHARMACEUTICA (1093 HK)
5.92%
WUXI BIOLOGICS (CA (2269 HK)
5.17%
ZAI LAB LTD (ZLAB)
4.62%
SINO BIOPHARMACEUT (1177 HK)
4.6%
LIVZON PHARMACEUTI (1513 HK)
4.58%
HANSOH PHARMACEUTI (3692 HK)
4.51%
CHINA MEDICAL SYS (867 HK)
3.97%
HUTCHISON CHINA MEDITECH LTD SPONSORED ADR (HCM)
3.59%
INNOVENT BIOLOGICS (1801 HK)
3.54%
SINOPHARM GROUP CO (1099 HK)
3.54%
YICHANG HEC CHANGJ (1558 HK)
3.38%
BEIGENE LTD (BGNE)
3.35%
SSY GROUP LIMITED (2005 HK)
3.15%
CHINA BIOLOGIC PRODS HLDGS INC COM (CBPO)
3.14%
SHANGHAI PHARMACEU (2607 HK)
3.13%
SHANGHAI FOSUN PHA (2196 HK)
2.94%
GENSCRIPT BIOTECH (1548 HK)
2.92%
CELLULAR BIOMEDICINE GROUP INC COM NEW (CBMG)
2.66%
LUYE PHARMA GP LTD (2186 HK)
2.52%
CHINA RES PHARM GR (3320 HK)
2.5%
GUANGZHOU BAIYUNSH (874 HK)
2.34%
3SBIO INC (1530 HK)
2.33%
SHANGHAI JUNSHI BI (1877 HK)
2.18%
VIVA BIOTECH HOLDI (1873 HK)
2.08%
SHANGHAI HAOHAI BI (6826 HK)
2.03%
SIHUAN PHARM HLDG (460 HK)
1.75%
CASI PHARMACEUTICALS INC (CASI)
1.49%
Cash & Other (Cash&Other)
0.01%
Loncar CHINA BIOPHARMA ETF (CHNA)
0%

CHNA Technicals

Alpha

0

Beta

1.36

Leverage

Long

Standard Deviation

1.23

CHNA Dividends

Dividend Date

2019-12-23

Latest Dividend

0.04

Annual Dividend

0.04

Annual Dividend Rate

0.04

Annual Dividend Yield

0.15

CHNA Performance

YTD Return

5.68%

1 Year Return

18.63%

3 Year Return

0%

5 Year Return

0%

10 Year Return

4.36%

CHNA Related Articles

© 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.